Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesPayablesPrepaid AssetsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Cannabis Bioscience International Holdings (CBIH) Total Debt (2023 - 2025)

Cannabis Bioscience International Holdings' Total Debt history spans 3 years, with the latest figure at $264092.0 for Q4 2025.

  • For Q4 2025, Total Debt changed 0.0% year-over-year to $264092.0; the TTM value through Nov 2025 reached $264092.0, changed 0.0%, while the annual FY2025 figure was $264092.0, 5.91% up from the prior year.
  • Total Debt for Q4 2025 was $264092.0 at Cannabis Bioscience International Holdings, roughly flat from $264092.0 in the prior quarter.
  • Across five years, Total Debt topped out at $322729.0 in Q1 2025 and bottomed at $249361.0 in Q2 2024.
  • The 3-year median for Total Debt is $264092.0 (2023), against an average of $266723.7.
  • The largest annual shift saw Total Debt fell 5.58% in 2024 before it grew 25.79% in 2025.
  • A 3-year view of Total Debt shows it stood at $261579.0 in 2023, then increased by 0.96% to $264092.0 in 2024, then changed by 0.0% to $264092.0 in 2025.
  • Per Business Quant, the three most recent readings for CBIH's Total Debt are $264092.0 (Q4 2025), $264092.0 (Q3 2025), and $264092.0 (Q2 2025).